Intas Pharma appoints Parthiv Mehta as Vice President - Rest of Africa & International Fertility

Published On 2025-04-09 10:43 GMT   |   Update On 2025-04-09 10:53 GMT
Advertisement

Ahmedabad: Intas Pharma has announced the appointment of Parthiv Mehta as the new Vice President - Rest of Africa & International Fertility.

"We are delighted to welcome Parthiv Mehta as Vice President – Rest of Africa & International Fertility at Intas," the Company informed in a Linkedin post.

"Parthiv brings with him a wealth of experience in pharmaceutical marketing and business development, with a strong focus on strategic business models that unlock market opportunities across Africa and the Middle East. His proven track record in launching new products and building strong brands in these regions will be instrumental in driving our ambitious goals forward," Intas stated.

"Excited to join Intas and shape its global narrative through bold strategies, deepening our impact in African markets and the infertility therapy domain", Parthiv Mehta said.

Read also: Intas Pharmaceuticals Gets CDSCO Panel Nod To study Bevacizumab Solution for Injection

Parthiv is a pharmaceutical industry professional with more than 25 years of experience in emerging markets with globally acclaimed pharmaceutical companies.

He joins Intas from Glenmark Pharmaceutics. Prior to this, he was head of healthcare division at Tata International. His career also includes roles at Dr. Reddy’s Laboratories, GSK, and Indoco Remedies.

Mehta holds a Bachelor of Pharmacy degree from SVB College of Pharmacy, University of Mumbai, and a Master’s in Marketing Management from Welingkar Institute of Management.

Read also: Intas Pharmaceutical Gets CDSCO Panel Nod to study Vedolizumab Powder for Concentrate for Solution for Infusion

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News